-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Supernus Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2018.
- Supernus Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.1M, a 134% increase year-over-year.
- Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2018 was -$4.27M, a 496% decline from 2017.
- Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2017 was $1.08M.
- Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2016 was -$3.85M, a 38.3% increase from 2015.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)